Bucelipase alfa

DB16664InvestigationalProtein Based Therapies

Bucelipase alfa is under investigation in clinical trial NCT00743483 (Efficacy of Bucelipase Alfa (BSSL) in Patients With Cystic Fibrosis and Pancreatic Insufficiency).

Mechanism: Pharmacologically active on Bile salt-activated lipase
Curator reviewed
Also known as: rhBSSL
Code names: COE 311

Resolves to

Compound

UNII3C617U1K19CAS9026-00-0

Targets

P19835CEL

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Bucelipase alfa, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account